Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Interaction of Hypericin with SARS-CoV-2 Reveals a Multimodal Antiviral Activity.
Delcanale P, Uriati E, Mariangeli M, Mussini A, Moreno A, Lelli D, Cavanna L, Bianchini P, Diaspro A, Abbruzzetti S, Viappiani C. Delcanale P, et al. Among authors: cavanna l. ACS Appl Mater Interfaces. 2022 Mar 30;14(12):14025-14032. doi: 10.1021/acsami.1c22439. Epub 2022 Mar 18. ACS Appl Mater Interfaces. 2022. PMID: 35302731 Free PMC article.
Hypericin-Apomyoglobin: An Enhanced Photosensitizer Complex for the Treatment of Tumor Cells.
Bianchini P, Cozzolino M, Oneto M, Pesce L, Pennacchietti F, Tognolini M, Giorgio C, Nonell S, Cavanna L, Delcanale P, Abbruzzetti S, Diaspro A, Viappiani C. Bianchini P, et al. Among authors: cavanna l. Biomacromolecules. 2019 May 13;20(5):2024-2033. doi: 10.1021/acs.biomac.9b00222. Epub 2019 Apr 25. Biomacromolecules. 2019. PMID: 30995399
Enhanced photosensitizing properties of protein bound curcumin.
Cozzolino M, Delcanale P, Montali C, Tognolini M, Giorgio C, Corrado M, Cavanna L, Bianchini P, Diaspro A, Abbruzzetti S, Viappiani C. Cozzolino M, et al. Among authors: cavanna l. Life Sci. 2019 Sep 15;233:116710. doi: 10.1016/j.lfs.2019.116710. Epub 2019 Jul 29. Life Sci. 2019. PMID: 31369762
Targeted photoimmunotherapy for cancer.
Mussini A, Uriati E, Bianchini P, Diaspro A, Cavanna L, Abbruzzetti S, Viappiani C. Mussini A, et al. Among authors: cavanna l. Biomol Concepts. 2022 Mar 19;13(1):126-147. doi: 10.1515/bmc-2022-0010. Biomol Concepts. 2022. PMID: 35304984 Free article.
A photosensitizing fusion protein with targeting capabilities.
Bruno S, Margiotta M, Cozzolino M, Bianchini P, Diaspro A, Cavanna L, Tognolini M, Abbruzzetti S, Viappiani C. Bruno S, et al. Among authors: cavanna l. Biomol Concepts. 2022 Mar 29;13(1):175-182. doi: 10.1515/bmc-2022-0014. Biomol Concepts. 2022. PMID: 35355498 Free article.
Impact of the COVID-19 pandemic on the oncologic activities (diagnosis, treatment, clinical trials enrollment) of a general hospital in a district with high prevalence of SARS-COV-2 in Italy.
Ambroggi M, Citterio C, Vecchia S, Riva A, Mordenti P, Cavanna L. Ambroggi M, et al. Among authors: cavanna l. Support Care Cancer. 2022 Apr;30(4):3225-3231. doi: 10.1007/s00520-021-06667-y. Epub 2022 Jan 3. Support Care Cancer. 2022. PMID: 34977981 Free PMC article.
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study.
Lasagna A, Bergami F, Lilleri D, Percivalle E, Quaccini M, Alessio N, Comolli G, Sarasini A, Sammartino JC, Ferrari A, Arena F, Secondino S, Cicognini D, Schiavo R, Lo Cascio G, Cavanna L, Baldanti F, Pedrazzoli P, Cassaniti I. Lasagna A, et al. Among authors: cavanna l. ESMO Open. 2022 Apr;7(2):100458. doi: 10.1016/j.esmoop.2022.100458. Epub 2022 Mar 11. ESMO Open. 2022. PMID: 35427842 Free PMC article.
325 results